Webpackaging logo

Aptar CSP Technologies Earns ISO Quality Certifications for Medical Device Production

  • Aptar CSP Technologies
Health, Pharmaceuticals, OTC (Over the Counter) Drugs, Prescription Drugs, Medical, Diagnostics, Laboratory, Testing, Certification, ISO Certifications

Aptar CSP Technologies, a leader in material science and active packaging solutions (part of AptarGroup, Inc.), earned the International Organization for Standardization ISO 13485:2016 certification for both its U.S. and France-based plants. These internationally recognized standards set the requirements for a quality management system specific to the medical device industry.

An ISO 13485-approved site ensures consistent design, development, production, installation, and delivery of medical devices that are safe for their intended purpose. The ISO certifications come at a critical time as the company is currently preparing for commercialization of a new medical device using its proprietary 3-Phase Activ-Polymer platform technology.

In addition to this imminent medical device commercialization, he company’s patented Activ-Film technology is currently integrated into implantable medical devices to control the microclimate of the device, extending use life and improving performance. The technology can also be engineered as a critical component of the overall delivery system.

“With this ISO certification, we are well-positioned to serve our current and future medical device partners,” said Badre Hammond, VP Commercial Operations, Aptar CSP Technologies. “As we broaden our portfolio of offerings, we continue to invest in our quality systems and operational excellence to support continued growth.”

See also

Aptar CSP Technologies’ Activ-Blister™ Solutions Now Available for Manufacturing in the EMEA Region

Aptar CSP Technologies, part of AptarGroup, Inc. and a leader in active material science solutions to ensure product protection, extend shelf life and improve patient experience, announces a new manufacturing site able to produce its Activ-Blister™ Solutions for oral slide dose drugs in Europe. The move is part of a key strategic effort to expand production of Activ-Blister™ technology globally.

Aptar CSP presents 'rethinking oral solid dose packaging' webinar

Aptar CSP Technologies – a leader in active packaging solutions that ensure product protection, enhance brand recognition and improve use experiences, and part of AptarGroup Inc – is presenting its Activ-Blister Solutions for the protection of moisture and oxygen-sensitive tablets and capsules, alongside FreeThink Technologies and its ASAPprime technology for accelerated shelf-life determination. The combination is a “right the first time” approach to stability challenges and blister package design that virtually eliminates protracted testing and costly reformulations.

CSP Technologies' focus for enhancing the shelf life for transdermal and oral solid dose drugs

Despite being two very different drug delivery platforms, oral solid doses and transdermal patches can face similar packaging headspace challenges that impact shelf life; besides moisture and oxygen ingress, exposure to certain conditions can lead to the formation of volatile organic compounds (VOCs) and other gases that, in turn, may interact with drug products and capsules, adversely impacting their stability.

  • Company News
  • English
  • Modified 20 Apr 2021
  • Hits 561